Dr. Reddy’s launches generic Tobi
Dr. Reddy’s is introducing tobramycin inhalation solution. The product is the generic of Mylans‘s Tobi (tobramycin) inhalation solution
The Tobi (tobramycin) inhalation solution brand and generic had a market value of approximately $97 million, for the most recent 12 months ended April 2019, according to IQVIA.
Dr. Reddy’s product is available in a 300 mg/5 mL single-dose ampule.
The Tobi (tobramycin) inhalation solution brand and generic had a market value of approximately $97 million, for the most recent 12 months ended April 2019, according to IQVIA.
Dr. Reddy’s product is available in a 300 mg/5 mL single-dose ampule.